THE PROGNOSTIC-SIGNIFICANCE OF THE HALF-LIFE OF SERUM CA-125 IN PATIENTS RESPONDING TO CHEMOTHERAPY FOR EPITHELIAL OVARIAN-CARCINOMA

被引：62
|
作者：
HAWKINS, RE
ROBERTS, K
WILTSHAW, E
MUNDY, J
FRYATT, IJ
MCCREADY, VR
机构：
[1] ROYAL MARSDEN HOSP,DEPT MED,FULHAM RD,LONDON SW3 6JJ,ENGLAND
[2] ROYAL MARSDEN HOSP,DEPT NUCL MED,LONDON SW3 6JJ,ENGLAND
来源：
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 1989年 / 96卷 / 12期
关键词：
D O I：
10.1111/j.1471-0528.1989.tb06301.x
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1395 / 1399
页数：5
相关论文
共 50 条
  • [31] IMMUNOCYTOCHEMICAL AND SEROLOGICAL DETECTION OF CEA AND CA-125 IN OVARIAN-CARCINOMA
    WEIKEL, W
    WELLENS, E
    BRUMM, C
    MOBUS, V
    BECK, T
    MITZE, M
    TUMORDIAGNOSTIK & THERAPIE, 1994, 15 (04) : 134 - 142
  • [32] USE OF THE CA-125 ANTIGEN IN DIAGNOSIS AND MONITORING OF OVARIAN-CARCINOMA
    BAST, RC
    KNAPP, RC
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1985, 19 (06): : 354 - 356
  • [33] EVALUATION OF CA-125 AS TUMOR-MARKER IN OVARIAN-CARCINOMA
    SCHRUURS, B
    VANKRIEKEN, L
    DECKERS, C
    LONGUEVILLE, J
    DEHERTOGH, R
    THOMAS, K
    TUMOUR BIOLOGY, 1985, 6 (04): : 417 - 417
  • [34] PREDICTIVE VALUE OF CA-125 FOR OVARIAN-CARCINOMA IN PATIENTS PRESENTING WITH PELVIC MASSES
    OCONNELL, GJ
    RYAN, E
    MURPHY, KJ
    PREFONTAINE, M
    OBSTETRICS AND GYNECOLOGY, 1987, 70 (06): : 930 - 932
  • [35] AN ASSESSMENT OF THE VALUE OF SERUM CA 125 MEASUREMENTS IN THE MANAGEMENT OF EPITHELIAL OVARIAN-CARCINOMA
    GARD, GB
    HOUGHTON, CRS
    GYNECOLOGIC ONCOLOGY, 1994, 53 (03) : 283 - 289
  • [36] PROGNOSTIC-SIGNIFICANCE OF SERUM CA-125 ANTIGEN-ASSAY IN PATIENTS WITH NONSMALL CELL LUNG-CANCER
    DIEZ, M
    TORRES, A
    POLLAN, H
    GOMEZ, A
    ORTEGA, D
    MAESTRO, ML
    GRANELL, J
    BALIBREA, JL
    CANCER, 1994, 73 (05) : 1368 - 1376
  • [37] Prognostic significance of elevated pretreatment serum CA-125 in patients (pts) with epithelial ovarian cancer (CEO) treated with surgery and platinum/taxane-based chemotherapy
    Prat, A.
    Parera, M.
    Peralta, S.
    Martinez, P.
    Adamo, B.
    Perez-Benavente, M.
    Gil-Moreno, A.
    Garcia, A.
    Martinez-Palones, J.
    Baselga, J.
    del Campo, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] CA-125 IN OVARIAN-CANCER - RELATION BETWEEN HALF-LIFE, DOUBLING TIME AND SURVIVAL
    WILLEMSE, PHB
    AALDERS, JG
    DEBRUYN, HWA
    MULDER, NH
    SLEIJFER, DT
    DEVRIES, EGE
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (08) : 993 - 995
  • [39] USE OF CA-125 RESPONSE TO PREDICT SURVIVAL PARAMETERS OF PATIENTS WITH ADVANCED OVARIAN-CARCINOMA
    RON, IG
    INBAR, M
    GELERNTER, I
    LEWYSOHN, O
    AYALON, D
    DALE, J
    CHAITCHIK, S
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1994, 73 (08) : 658 - 662
  • [40] SERUM CA-125 AND SURVIVAL OF MICE INOCULATED WITH OVARIAN-CARCINOMA AND TREATED WITH ANTIESTROGEN, ESTROGEN, OR PROGESTIN
    HOLT, JA
    WAGGONER, SE
    LEE, EY
    HUBBY, MM
    HAMILTON, TC
    GYNECOLOGIC ONCOLOGY, 1987, 27 (03) : 282 - 293
12345